EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.
VentureMed Group Raises $28M in Series C Funding
VentureMed Group Closes $28M Series C Led by S3 Ventures